BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19539582)

  • 1. Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.
    Suter M; Meisinger-Henschel C; Tzatzaris M; Hülsemann V; Lukassen S; Wulff NH; Hausmann J; Howley P; Chaplin P
    Vaccine; 2009 Dec; 27(52):7442-50. PubMed ID: 19539582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.
    Wyatt LS; Carroll MW; Czerny CP; Merchlinsky M; Sisler JR; Moss B
    Virology; 1998 Nov; 251(2):334-42. PubMed ID: 9837798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
    Carroll MW; Moss B
    Virology; 1997 Nov; 238(2):198-211. PubMed ID: 9400593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
    Zwilling J; Sliva K; Schwantes A; Schnierle B; Sutter G
    Virology; 2010 Sep; 404(2):231-9. PubMed ID: 20627347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
    Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
    J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
    Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
    Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
    Meyer H; Sutter G; Mayr A
    J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.
    Antoine G; Scheiflinger F; Dorner F; Falkner FG
    Virology; 1998 May; 244(2):365-96. PubMed ID: 9601507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
    Meisinger-Henschel C; Schmidt M; Lukassen S; Linke B; Krause L; Konietzny S; Goesmann A; Howley P; Chaplin P; Suter M; Hausmann J
    J Gen Virol; 2007 Dec; 88(Pt 12):3249-3259. PubMed ID: 18024893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
    Ferrer MF; Zanetti FA; Calamante G
    Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
    Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
    J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
    Fischer SF; Ludwig H; Holzapfel J; Kvansakul M; Chen L; Huang DC; Sutter G; Knese M; Häcker G
    Cell Death Differ; 2006 Jan; 13(1):109-18. PubMed ID: 16003387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
    Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
    J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
    Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
    Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses.
    Hodge JW; Poole DJ; Aarts WM; Gómez Yafal A; Gritz L; Schlom J
    Cancer Res; 2003 Nov; 63(22):7942-9. PubMed ID: 14633725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain.
    Spehner D; Drillien R; Proamer F; Houssais-Pêcheur C; Zanta MA; Geist M; Dott K; Balloul JM
    Virology; 2000 Jul; 273(1):9-15. PubMed ID: 10891402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
    Erez N; Wyatt LS; Americo JL; Xiao W; Moss B
    J Virol; 2021 Sep; 95(19):e0110421. PubMed ID: 34232734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Peng C; Moss B
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3759-3767. PubMed ID: 32019881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine.
    Blanchard TJ; Alcami A; Andrea P; Smith GL
    J Gen Virol; 1998 May; 79 ( Pt 5)():1159-67. PubMed ID: 9603331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.
    Sánchez-Sampedro L; Gómez CE; Mejías-Pérez E; Pérez-Jiménez E; Oliveros JC; Esteban M
    J Virol; 2013 Jun; 87(12):6955-74. PubMed ID: 23596295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.